openPR Logo
Press release

Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | by type rat custom monoclonal antibody, rabbit custom monoclonal antibody, others – Asserts MRFR

07-17-2018 11:23 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Monoclonal Antibody Custom Service Market

Monoclonal Antibody Custom Service Market

Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa.

Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515

Monoclonal Antibody Custom Service Market – Overview

It is estimated that monoclonal antibody custom service market is expected to grow at a CAGR 10.84% during the forecast period 2017-2023. Monoclonal Antibodies are a class of antibodies derived from a single ancestral cell. These antibodies have tendency to grow indefinitely and are very particular for a location in the body derived from a single clone. Monoclonal antibody custom service offers the development of both rat and mouse hybridomas for the production of custom monoclonal antibodies from synthesized peptide or recombinant protein antigens. These services provide a comprehensive services for antibody cloning, expression, engineering, and purification in addition to custom antibody development for multiple pharmaceutical and biotechnological companies. Increasing investment in research & development, increasing prevalence of chronic diseases, infections, and rising occurrence of immunological diseases are the key factors driving the market growth. However, high cost of monoclonal antibody services may hinder the growth of market to an extent.

Industry Segments:

The global monoclonal antibody custom service market is segmented on the basis of type, application, and end-users.

On the basis of type, the market is segmented into rat custom monoclonal antibody, rabbit custom monoclonal antibody, and others.

On the basis of application, the market is classified into diagnostic application, therapeutic application, and protein purification. The diagnostic application is sub-segmented into biochemical analysis, and diagnostic imaging. The biochemical analysis is further segmented into pregnancy, cancer, hormonal disorder, and infectious diseases. The diagnostic imaging is further segmented into cardiovascular diseases, cancer, and bacterial infections. The therapeutic application is further segmented into MAb as therapeutic agents, MAb as targeting agents.

Detailed Regional Analysis:

The Americas dominates the monoclonal antibody custom service market owing to the presence of patient population, well-developed technology, high healthcare expenditure and the presence of the leading players. According to the National Cancer Institute in 2016, 1.6 million new cancer cases were diagnosed in the US.

Europe holds the second position in the monoclonal antibody custom service market. It is expected that the support provided by the government bodies for research & development drives the market in European region.

Asia-Pacific region is projected to be the fastest growing region during the forecast period. The high growth rate is due to increasing risk of infectious diseases in this region.

The Middle East and Africa holds the least share in the market owing to the presence of poor and slow developing countries, especially, in African region.

Ask to Expert @ https://www.marketresearchfuture.com/enquiry/4515

Major TOC of Monoclonal Antibody Custom Service Market research report- Global forecast till 2023:

1 Report Prologue

2 Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Monoclonal Antibody Custom Service Market, by Type

7 Global Monoclonal Antibody Custom Service Market, by Application

8 Global Monoclonal Antibody Custom Service Market, by End User

9 Global Monoclonal Antibody Custom Service Market, by Region

10 Company Landscape

11 Company Profiles

12   Conclusion

13 Appendix

Avail Stunning Discount @ https://www.marketresearchfuture.com/check-discount/4515

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | by type rat custom monoclonal antibody, rabbit custom monoclonal antibody, others – Asserts MRFR here

News-ID: 1129658 • Views: 252

More Releases from Market Research Future

Ethernet PHY Chip Market to Post 10.3% CAGR from 2020 and 2026 By Size, Share, C …
Market Overview Market Research Future (MRFR) projects that the global ethernet PHY chip market is set to expand at 10.3% CAGR between 2020 and 2026. The market is expected to surpass a valuation of the USD 14,200 Mn by the year 2026. Ethernet devices are used of support various types of physical media interfaces that requires high-speed networks. The rising application in digital televisions, gaming consoles, embedded telecom systems, set-top boxes is
Shortwave Infrared Market 2020 Global Industry Analysis By Identifying the Key M …
Market Synopsis: Shortwave infrared is sensitive to wavelengths ranging from 0.4 to 3 microns, which is 1,100 to 3,000 nanometers. This range is not visible to naked eyes, which is expected to lead to rising applications of the technology in the upcoming years. According to the study offered by Market Research Future MRFR), the global shortwave infrared market is anticipated to surpass USD 300 Mn mark by 2023 up from
Hybrid Fibre Coaxial (HFC) Market 2020 Size, Share, Growth, Trends, Product Spec …
Market Analysis Currently, hybrid fibre coaxial (HFC) is identified as one of the leading fibre optic technologies. In broadband communication, it uses optical fibre and coaxial cable combine, the major advantage of which, is that it offers greater enterprise video conferencing, voice transfer, telephony, and data services. Thus, the cost effictivness of HFC cables and their utility across industries and residential complexes can gain high earnings for the market. Moreover, the
Hybrid Fibre Coaxial (HFC) Market Size, Share, Top Key Players,Growth, Trends, P …
Market Analysis Currently, hybrid fibre coaxial (HFC) is identified as one of the leading fibre optic technologies. In broadband communication, it uses optical fibre and coaxial cable combine, the major advantage of which, is that it offers greater enterprise video conferencing, voice transfer, telephony, and data services. Thus, the cost effictivness of HFC cables and their utility across industries and residential complexes can gain high earnings for the market. Moreover, the

All 5 Releases


More Releases for Monoclonal

Global Custom Antibody Market | Types: Monoclonal, Polyclonal, Others
The Custom Antibody market report analyses the increasing demand for custom Antibody in different sectors like BioScience Companies, BioScience Research Institutions, Hospitals. The report consists with Key Players, Types, Applications & Regions. The Report consists of 109 pages with top 15 key players. Also, this report focuses on Custom Antibody market volume and value at the global level, regional level, and company level. From a global perspective, this report represents
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future. There has been a
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. In recent years the popularity
Global Monoclonal Antibodies Pipeline Insight 2015
Ever since the Nobel Prize was bestowed on the person who invented the technology which enabled the preparation of monoclonal antibodies in 1984, their use has considerably expanded far beyond the scientific realm. Paul Ehrlich framed a hypothesis that a “magic bullet” could be developed with an objective of targeting selective diseases. With the introduction and development of hybridoma technology by Kohler and Milstein, this hypothesis has become a reality.
Global Cancer Monoclonal Antibodies Market & Pipeline Insight
The recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers have increased their learning about the human body’s immune system, which has led to the achievement of significant number of regulatory milestones during this period. The use of mAbs for treating cancer has increased significantly. The rising market availability
Global Breast Cancer Monoclonal Antibodies Market Outlook 2020
Breast cancer incidences are increasing across the globe and conventional therapeutics have modest pharmacological efficacy. To surmount this issue, investigators came forth with monoclonal antibodies for breast cancer treatment which have targeted capabilities along with higher safety and efficacy levels. They have found that some receptors have overexpressed in cancerous cells due to which they could be identified and targeted. Monoclonal antibodies are highly customizable due to specific nature they